Search results for "Diabetes"
IM physicians join health inspections at the border
Two ACP members toured Customs and Border Protection (CBP) facilities near the Texas/Mexico border to evaluate the processes and environmental conditions affecting human health at the facilities.
https://immattersacp.org/archives/2023/01/im-physicians-join-health-inspections-at-the-border.htm
1 Jan 2023
New year, new chances to advocate for physicians, patients
ACP played an essential role in several important health policy wins for physicians and their patients in 2022.
https://immattersacp.org/archives/2023/01/new-year-new-chances-to-advocate-for-physicians-patients.htm
1 Jan 2023
15th annual Global Forum highlights lessons learned from COVID-19
At ACP's Global Forum in Chicago, attendees discussed how internal medicine specialists have been essential in addressing the challenges of the COVID-19 pandemic.
https://immattersacp.org/archives/2023/01/15th-annual-global-forum-highlights-lessons-learned-from-COVID-19.htm
1 Jan 2023
ADA updates diabetes standards of care for 2023
The American Diabetes Association (ADA) has changed its recommendations on hypertension cutoffs, use of statins, and treatment of patients with diabetes and chronic kidney disease, among other topics.
https://immattersacp.org/weekly/archives/2022/12/20/1.htm
20 Dec 2022
Dapagliflozin reduced risk for hospitalization in CKD patients with or without diabetes
A post hoc analysis of an industry-funded trial found that dapagliflozin reduced overall risk of hospitalization as well as risk of hospitalization ending in death in patients with chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/12/06/3.htm
6 Dec 2022
Complementary, integrative health services increasing in VA system
Use of complementary and integrative therapies, such as chiropractic care, acupuncture, massage therapy, and yoga, increased 70% over a three-year period in the Veterans Affairs (VA) health system after their availability was expanded.
https://immattersacp.org/weekly/archives/2022/12/06/5.htm
6 Dec 2022
GLP-1 receptor agonists associated with thyroid cancer
Patients taking a glucagon-like peptide-1 (GLP-1) receptor agonist had about one and a half times the risk of developing thyroid cancer compared to similar controls, according to an observational French study.
https://immattersacp.org/weekly/archives/2022/11/22/2.htm
22 Nov 2022
MKSAP Quiz: Follow-up for diabetes, hyperlipidemia, hypertension
A 68-year-old man is evaluated during a routine follow-up visit. Medical history is significant for type 2 diabetes mellitus, hyperlipidemia, hypertension, and aortofemoral bypass surgery 2 years ago. Following a physical exam, what is the most appropriate additional treatment?
https://immattersacp.org/weekly/archives/2022/11/15/3.htm
15 Nov 2022
Some newer diabetes drugs may help decrease risk of COPD exacerbation
A cohort study in the United Kingdom found that chronic obstructive pulmonary disease (COPD) exacerbations were less common in patients with type 2 diabetes and COPD taking glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors versus sulfonylureas.
https://immattersacp.org/weekly/archives/2022/11/08/4.htm
8 Nov 2022
Stopping renin-angiotensin system inhibitors in advanced CKD did not appear to affect eGFR
A randomized open-label trial in the United Kingdom found that withdrawal of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in patients with advanced chronic kidney disease (CKD) did not affect estimated glomerular filtration rate (eGFR).
https://immattersacp.org/weekly/archives/2022/11/08/2.htm
8 Nov 2022